RENAMIN (AMINO ACIDS) INJECTION
RENAMIN (AMINO ACIDS) INJECTION
Discontinued
DIN Number
02020564
Drug Class
Human
Market Date
Feb 2, 1996
Company
HC
baxter corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02020564
AIG Number1550855001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B05BA01 AMINO ACIDS
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification40:20.00
Health Canada Classification
ACTIVE INGREDIENTS (15)
GLYCINEActive
Strength: 300 MG / 100 ML
Monograph: GLYCINE
HISTIDINEActive
Strength: 420 MG / 100 ML
Monograph: HISTIDINE
L-ALANINEActive
Strength: 560 MG / 100 ML
Monograph: L-ALANINE
L-ARGININEActive
Strength: 630 MG / 100 ML
Monograph: L-ARGININE
L-ISOLEUCINEActive
Strength: 500 MG / 100 ML
Monograph: L-ISOLEUCINE
L-LEUCINEActive
Strength: 600 MG / 100 ML
Monograph: L-LEUCINE
L-LYSINE HYDROCHLORIDEActive
Strength: 450 MG / 100 ML
Monograph: L-LYSINE HYDROCHLORIDE
L-PHENYLALANINEActive
Strength: 490 MG / 100 ML
Monograph: L-PHENYLALANINE
L-PROLINEActive
Strength: 350 MG / 100 ML
Monograph: L-PROLINE
L-THREONINEActive
Strength: 380 MG / 100 ML
Monograph: L-THREONINE
L-TYROSINEActive
Strength: 40 MG / 100 ML
Monograph: L-TYROSINE
L-VALINEActive
Strength: 820 MG / 100 ML
Monograph: L-VALINE
METHIONINEActive
Strength: 500 MG / 100 ML
Monograph: METHIONINE
SERINEActive
Strength: 300 MG / 100 ML
Monograph: SERINE
TRYPTOPHANActive
Strength: 160 MG / 100 ML
Monograph: TRYPTOPHAN